Stock Price
15.84
Daily Change
0.69 4.55%
Monthly
-0.69%
Yearly
-15.16%
Q1 Forecast
14.69

Adma Biologics reported $3.59B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 3.49B 853M Sep/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
BioCryst Pharmaceuticals USD 1.7B 40M Mar/2026
Novavax USD 1.43B 340M Mar/2026
Takeda JPY 7.64T 774.9B Dec/2025